REGENXBIO Inc. (RGNX) Social Stream
REGENXBIO INC (RGNX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RGNX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 8 | $90 | $43 | $62.75 | $14.67 | 327.74% |
| 2022-01-10 | 8 | $90 | $29 | $59.25 | $14.67 | 303.89% |
| 2022-02-01 | 8 | $90 | $29 | $58.25 | $14.67 | 297.07% |
| 2022-02-14 | 8 | $90 | $29 | $57.5 | $14.67 | 291.96% |
| 2022-03-04 | 8 | $90 | $25 | $57 | $14.67 | 288.55% |
| 2022-03-22 | 7 | $82 | $25 | $52.428 | $14.67 | 257.38% |
| 2022-03-29 | 7 | $82 | $25 | $55.375 | $14.67 | 277.47% |
| 2022-04-11 | 8 | $82 | $25 | $55.375 | $14.67 | 277.47% |
| 2022-05-06 | 8 | $82 | $25 | $54.625 | $14.67 | 272.36% |
| 2022-06-10 | 8 | $82 | $25 | $54.125 | $14.67 | 268.95% |
| 2022-07-11 | 10 | $82 | $25 | $54.1 | $14.67 | 268.78% |
| 2022-08-04 | 10 | $82 | $25 | $54.4 | $14.67 | 270.82% |
| 2022-08-31 | 10 | $82 | $25 | $54.3 | $14.67 | 270.14% |
| 2022-10-03 | 8 | $70 | $25 | $51.5 | $14.67 | 251.06% |
| 2022-10-04 | 9 | $70 | $25 | $48.555 | $14.67 | 230.98% |
| 2022-10-25 | 9 | $70 | $13 | $47.222 | $14.67 | 221.9% |
| 2022-11-04 | 9 | $65 | $13 | $44.555 | $14.67 | 203.72% |
| 2022-11-06 | 9 | $65 | $14 | $44.666 | $14.67 | 204.47% |
| 2022-11-21 | 9 | $65 | $14 | $44.444 | $14.67 | 202.96% |
| 2022-11-30 | 9 | $65 | $15 | $44.555 | $14.67 | 203.72% |
| 2022-12-15 | 9 | $65 | $15 | $44 | $14.67 | 199.93% |
| 2023-02-14 | 9 | $65 | $14 | $43.889 | $14.67 | 199.18% |
| 2023-03-01 | 9 | $65 | $14 | $43.666 | $14.67 | 197.66% |
| 2023-03-03 | 9 | $65 | $14 | $43.222 | $14.67 | 194.63% |
| 2023-05-05 | 9 | $65 | $12 | $42.222 | $14.67 | 187.81% |
| 2023-05-08 | 9 | $65 | $12 | $41.222 | $14.67 | 181% |
| 2023-05-09 | 9 | $65 | $12 | $40.889 | $14.67 | 178.73% |
| 2023-06-06 | 10 | $65 | $12 | $37.75 | $14.67 | 157.33% |
| 2023-08-04 | 8 | $65 | $12 | $37.75 | $14.67 | 157.33% |
| 2023-08-29 | 8 | $65 | $12 | $37.625 | $14.67 | 156.48% |
| 2023-10-04 | 8 | $65 | $13 | $37.75 | $14.67 | 157.33% |
| 2023-10-18 | 8 | $65 | $15 | $38 | $14.67 | 159.03% |
| 2023-10-31 | 9 | $65 | $15 | $37.666 | $14.67 | 156.76% |
| 2023-11-06 | 9 | $65 | $15 | $37.111 | $14.67 | 152.97% |
| 2023-11-10 | 9 | $65 | $20 | $37.333 | $14.67 | 154.49% |
| 2023-11-14 | 9 | $65 | $20 | $37.444 | $14.67 | 155.24% |
The Trend in the Analyst Price Target
Over the past 19 months, RGNX's average price target has gone down $17.38.
RGNX reports an average of 110.03% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-05 | 9 | 65 | 12 | 42.222 | 18.88 | 123.63% |
| 2023-05-09 | 9 | 65 | 12 | 40.889 | 18.71 | 118.54% |
| 2023-11-14 | 9 | 65 | 20 | 37.444 | 19.05 | 96.56% |
| 2023-11-14 | 10 | 65 | 20 | 39.800 | 19.05 | 108.92% |
| 2023-11-14 | 9 | 61 | 20 | 38.000 | 19.05 | 99.48% |
RGNX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.6 | 7 | 0 | 3 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
RGNX's average broker recommendation rating improved by 0.21 over the prior 21 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RGNX as an investment opportunity.
- In the context of all US stocks, REGENXBIO INC's variance in analysts' estimates is lower than -3815.54% of them.
- REGENXBIO INC's upside potential (average analyst target price relative to current price) is higher than 3774.76% of all US stocks.
- REGENXBIO INC's average analyst price target is greater than 2838.06% of Pharmaceutical Products stocks.
- In terms of how REGENXBIO INC fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 2640.23% of that group.
Stocks similar to REGENXBIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are HALO, BCRX, and SNDL.
View All Top Stocks by Price Target
Is RGNX a Buy, Hold or Sell? See the POWR Ratings now!